Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Increasing Incidence of Cancer of the Prostate: The Experience of Black and White Men in the Detroit Metropolitan Area

Increasing Incidence of Cancer of the Prostate: The Experience of Black and White Men in the... Abstract Background: Prostate cancer mortality and incidence rates have been gradually increasing for decades in the United States, with an accelerated increase in incidence noted in the past several years. This study explores in detail the occurrence of prostate cancer in southeast Michigan from 1973 through 1991. Methods: Data from the National Cancer Institute Surveillance, Epidemiology, and End Results program are analyzed with emphasis on time trends by race, age, stage, and treatment. Results: Population-based rates for prostate cancer increased by 70% between 1988 and 1991. Increases are most pronounced for early stage disease and among whites compared with blacks. Corresponding increases in treatment with radical prostatectomy are also observed. Conclusion: Increased incidence of prostate cancer is likely a result of widespread use of prostate-specific antigen.(Arch Intern Med. 1994;154:1211-1216) References 1. Boring CC, Squires TS, Tong T. Cancer statistics: 1993 . CA J Clin. 1993;43: 7-26.Crossref 2. Miller BA, Ries LAG, Hankey BF, Kosary CL, Edwards BK, eds. Cancer Statistics Review: 1973-1989 . Bethesda, Md: National Cancer Institute; 1992. NIH Publication No. 92-2789. 3. Muir CS, Nectoux J, Staszewski J. The epidemiology of prostatic cancer . Acta Oncol. 1991;30:133-140.Crossref 4. Potosky AL, Kessler L, Gridley G, Brown CC, Horm JW. Rise in prostatic cancer incidence associated with increased use of transurethral resection . J Natl Cancer Inst. 1990;82:1624-1628.Crossref 5. Severson RK. Have transurethral resections contributed to the increasing incidence of prostatic cancer? J Natl Cancer Inst. 1990;82:1597-1598.Crossref 6. Hessmat MY, Kovi J, Rao MS, Mohla S, Spurin DW, Jean-Baptiste G. Review of prostatic surgical procedures at a predominantly black hospital: a 22-year study . J Natl Med Assoc. 1992;84:677-680. 7. Oesterling JE, Martin SK, Bergstralh EJ, Lowe FC. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer . JAMA . 1993; 269:57-60.Crossref 8. Gerber GS, Thompson IM, Thisted R, Choda GW. Disease-specific survival following routine prostate cancer screening by digital rectal examination . JAMA . 1993;269:61-64.Crossref 9. Sutton MA, Gibbons RP, Correa RJ Jr. Is deleting the digital rectal examination a good idea? West J Med. 1991;155:43-46. 10. Moon TD, Clegan S. Prostate cancer screening in younger men: prostate-specific antigen and public awareness . Urology . 1991;38:216-219.Crossref 11. Friedman GD, Hiatt RA, Quesenberry CP Jr, Selby JV. Case-control study of screening for prostatic cancer by digital rectal examinations . Lancet . 1991; 337:1526-1529.Crossref 12. Cooner WH, Mosley BR, Rutherford CL Jr, et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen . J Urol. 1990;143:1146-1154. 13. Lee F, Torp-Pedersen ST, Littrup PJ, McLeary RD. Is ultrasound of the prostate indicated for screening purposes? Fam Pract . 1988;27:521-524. 14. Babaian RJ, Mettlin C, Kane R, et al. The relationship of prostate-specific antigen to digital rectal examination and transrectal ultrasonography . Cancer . 1992; 69:1195-1200.Crossref 15. Muschenheim F, Omarbasha B, Kardjian PM, Mondou EN. Screening for carcinoma of the prostate with prostate specific antigen . Ann Clin Lab Sci. 1991; 21:371-380. 16. Littrup PJ, Lee F, Mettlin C. Prostate cancer screening: current trends and future implications . CA Cancer J Clin. 1992;42:198-211.Crossref 17. Huben RP. Early detection of prostate cancer . Semin Surg Oncol. 1989;5:201-204.Crossref 18. Mettlin C, Jones GW, Murphy GP. Trends in prostate cancer care in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer . CA Cancer J Clin. 1993; 43:83-91.Crossref 19. Swanson GM, Young JL. Trends in cancer incidence in metropolitan Detroit, 1937-1977: leads for prevention . Prev Med. 1983;12:403-420.Crossref 20. Mebane C, Gibbs T, Horm J. Current status of prostate cancer in North American black males . Natl Med Assoc. 1990;82:782-788. 21. Polednak AP, Flannery JT. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut . Cancer . 1992; 70:2152-2158.Crossref 22. Whittemore AS, Keller JB, Betensky R. Low-grade latent prostate cancer volume: predictor of clinical cancer incidence? J Natl Cancer Inst. 1991;83:12311235.Crossref 23. Lange PH. Early detection for prostate cancer? J Natl Cancer Inst. 1991;83: 1199-1201.Crossref 24. Whitmore WF. Hormone therapy in prostatic cancer . Am J Med. 1956;21:697-713.Crossref 25. Targonski PV, Guinan P, Phillips CW. Prostate cancer: the stage disadvantage in the black male . J Natl Med Assoc. 1991;83:1094-1096. 26. Johansson JE, Andersson SO, Krusemo UB, Adami HO, Bergstrom R, Wolfgang K. Natural history of localized prostatic cancer . Lancet . 1989;2:799-803.Crossref 27. Whitmore WF Jr. Management of clinically localized prostatic cancer: an unsolved problem . JAMA . 1993;269:2676-2677.Crossref 28. Johansson JE, Adami HO, Andersson SO, Bergstrom R, Holmberg L, Krusemo UB. High 10-year survival rate in patients with early, untreated prostatic cancer . JAMA . 1992;267:2191-2196.Crossref 29. Carr TW. Natural history of prostate cancer . Lancet 1993;341:91-92.Crossref 30. Lu-Yao GL, McLerran D, Wasson J, Wennberg JE. An assessment of radical prostatectomy: time trends, geographic variation, and outcomes . JAMA . 1993; 269:2633-2636.Crossref 31. Iverson P, Torp-Pedersen ST. Screening for prostatic cancer: investigational models . Acta Oncol. 1991;30:281-284.Crossref 32. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer . JAMA . 1993;269:2650-2658.Crossref 33. Lange PH. The next era for prostate cancer . JAMA . 1993;269:95-96.Crossref 34. Swanson GM, Ragheb NE, Lin CS, et al. Breast cancer among black and white women in the 1980s: changing patterns in the United States by race, age, and extent of disease . Cancer . 1993;72:788-798.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Internal Medicine American Medical Association

Increasing Incidence of Cancer of the Prostate: The Experience of Black and White Men in the Detroit Metropolitan Area

Loading next page...
 
/lp/american-medical-association/increasing-incidence-of-cancer-of-the-prostate-the-experience-of-black-9yzRN66o1K
Publisher
American Medical Association
Copyright
Copyright © 1994 American Medical Association. All Rights Reserved.
ISSN
0003-9926
eISSN
1538-3679
DOI
10.1001/archinte.1994.00420110051006
Publisher site
See Article on Publisher Site

Abstract

Abstract Background: Prostate cancer mortality and incidence rates have been gradually increasing for decades in the United States, with an accelerated increase in incidence noted in the past several years. This study explores in detail the occurrence of prostate cancer in southeast Michigan from 1973 through 1991. Methods: Data from the National Cancer Institute Surveillance, Epidemiology, and End Results program are analyzed with emphasis on time trends by race, age, stage, and treatment. Results: Population-based rates for prostate cancer increased by 70% between 1988 and 1991. Increases are most pronounced for early stage disease and among whites compared with blacks. Corresponding increases in treatment with radical prostatectomy are also observed. Conclusion: Increased incidence of prostate cancer is likely a result of widespread use of prostate-specific antigen.(Arch Intern Med. 1994;154:1211-1216) References 1. Boring CC, Squires TS, Tong T. Cancer statistics: 1993 . CA J Clin. 1993;43: 7-26.Crossref 2. Miller BA, Ries LAG, Hankey BF, Kosary CL, Edwards BK, eds. Cancer Statistics Review: 1973-1989 . Bethesda, Md: National Cancer Institute; 1992. NIH Publication No. 92-2789. 3. Muir CS, Nectoux J, Staszewski J. The epidemiology of prostatic cancer . Acta Oncol. 1991;30:133-140.Crossref 4. Potosky AL, Kessler L, Gridley G, Brown CC, Horm JW. Rise in prostatic cancer incidence associated with increased use of transurethral resection . J Natl Cancer Inst. 1990;82:1624-1628.Crossref 5. Severson RK. Have transurethral resections contributed to the increasing incidence of prostatic cancer? J Natl Cancer Inst. 1990;82:1597-1598.Crossref 6. Hessmat MY, Kovi J, Rao MS, Mohla S, Spurin DW, Jean-Baptiste G. Review of prostatic surgical procedures at a predominantly black hospital: a 22-year study . J Natl Med Assoc. 1992;84:677-680. 7. Oesterling JE, Martin SK, Bergstralh EJ, Lowe FC. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer . JAMA . 1993; 269:57-60.Crossref 8. Gerber GS, Thompson IM, Thisted R, Choda GW. Disease-specific survival following routine prostate cancer screening by digital rectal examination . JAMA . 1993;269:61-64.Crossref 9. Sutton MA, Gibbons RP, Correa RJ Jr. Is deleting the digital rectal examination a good idea? West J Med. 1991;155:43-46. 10. Moon TD, Clegan S. Prostate cancer screening in younger men: prostate-specific antigen and public awareness . Urology . 1991;38:216-219.Crossref 11. Friedman GD, Hiatt RA, Quesenberry CP Jr, Selby JV. Case-control study of screening for prostatic cancer by digital rectal examinations . Lancet . 1991; 337:1526-1529.Crossref 12. Cooner WH, Mosley BR, Rutherford CL Jr, et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen . J Urol. 1990;143:1146-1154. 13. Lee F, Torp-Pedersen ST, Littrup PJ, McLeary RD. Is ultrasound of the prostate indicated for screening purposes? Fam Pract . 1988;27:521-524. 14. Babaian RJ, Mettlin C, Kane R, et al. The relationship of prostate-specific antigen to digital rectal examination and transrectal ultrasonography . Cancer . 1992; 69:1195-1200.Crossref 15. Muschenheim F, Omarbasha B, Kardjian PM, Mondou EN. Screening for carcinoma of the prostate with prostate specific antigen . Ann Clin Lab Sci. 1991; 21:371-380. 16. Littrup PJ, Lee F, Mettlin C. Prostate cancer screening: current trends and future implications . CA Cancer J Clin. 1992;42:198-211.Crossref 17. Huben RP. Early detection of prostate cancer . Semin Surg Oncol. 1989;5:201-204.Crossref 18. Mettlin C, Jones GW, Murphy GP. Trends in prostate cancer care in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer . CA Cancer J Clin. 1993; 43:83-91.Crossref 19. Swanson GM, Young JL. Trends in cancer incidence in metropolitan Detroit, 1937-1977: leads for prevention . Prev Med. 1983;12:403-420.Crossref 20. Mebane C, Gibbs T, Horm J. Current status of prostate cancer in North American black males . Natl Med Assoc. 1990;82:782-788. 21. Polednak AP, Flannery JT. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut . Cancer . 1992; 70:2152-2158.Crossref 22. Whittemore AS, Keller JB, Betensky R. Low-grade latent prostate cancer volume: predictor of clinical cancer incidence? J Natl Cancer Inst. 1991;83:12311235.Crossref 23. Lange PH. Early detection for prostate cancer? J Natl Cancer Inst. 1991;83: 1199-1201.Crossref 24. Whitmore WF. Hormone therapy in prostatic cancer . Am J Med. 1956;21:697-713.Crossref 25. Targonski PV, Guinan P, Phillips CW. Prostate cancer: the stage disadvantage in the black male . J Natl Med Assoc. 1991;83:1094-1096. 26. Johansson JE, Andersson SO, Krusemo UB, Adami HO, Bergstrom R, Wolfgang K. Natural history of localized prostatic cancer . Lancet . 1989;2:799-803.Crossref 27. Whitmore WF Jr. Management of clinically localized prostatic cancer: an unsolved problem . JAMA . 1993;269:2676-2677.Crossref 28. Johansson JE, Adami HO, Andersson SO, Bergstrom R, Holmberg L, Krusemo UB. High 10-year survival rate in patients with early, untreated prostatic cancer . JAMA . 1992;267:2191-2196.Crossref 29. Carr TW. Natural history of prostate cancer . Lancet 1993;341:91-92.Crossref 30. Lu-Yao GL, McLerran D, Wasson J, Wennberg JE. An assessment of radical prostatectomy: time trends, geographic variation, and outcomes . JAMA . 1993; 269:2633-2636.Crossref 31. Iverson P, Torp-Pedersen ST. Screening for prostatic cancer: investigational models . Acta Oncol. 1991;30:281-284.Crossref 32. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer . JAMA . 1993;269:2650-2658.Crossref 33. Lange PH. The next era for prostate cancer . JAMA . 1993;269:95-96.Crossref 34. Swanson GM, Ragheb NE, Lin CS, et al. Breast cancer among black and white women in the 1980s: changing patterns in the United States by race, age, and extent of disease . Cancer . 1993;72:788-798.Crossref

Journal

Archives of Internal MedicineAmerican Medical Association

Published: Jun 13, 1994

References